CAS: 906669-07-6 - 3H-1,2,4-Triazol-3-one,5-(2,4-dihydroxyphenyl)-2,4-dihydro-4-(4-methylphenyl)-
Formula:C15H13N3O3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | KPLH1130 REF: TM-T11765CAS: 906669-07-6 | 98.43% | 82.00 €~2,270.00 € | Mon 13 May 24 |
 | KPLH1130 REF: 3D-GLB66907CAS: 906669-07-6 | Min. 95% | To inquire | Tue 25 Jun 24 |
KPLH1130
CAS:906669-07-6
KPLH1130, a specific pyruvate dehydrogenase kinase (PDK) inhibitor, enhances glucose tolerance in mice fed a …
Formula:
C15H13N3O3
Purity:
98.43%
Color and Shape:
Solid
Molecular weight:
283.28
- Inhibitors
- Apoptosis
- Metabolism
- Dehydrogenase
- See more categories
- PI3K/Akt/mTOR Signaling
- PDK
Ref: TM-T11765
| 1mg | 82.00 € | |
| 5mg | 212.00 € | |
| 10mg | 343.00 € | |
| 25mg | 578.00 € | |
| 50mg | 827.00 € | |
| 100mg | 1,105.00 € | |
| 500mg | 2,270.00 € | |
| 1ml*10 (DMSO) | 185.00 € |
Estimated delivery in United States, on Monday 13 May 2024
KPLH1130
CAS:906669-07-6
KPLH1130 is an analog of a protein kinase inhibitor that has shown promising results as …
Formula:
C15H13N3O3
Purity:
Min. 95%
Molecular weight:
283.28 g/mol
Ref: 3D-GLB66907
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 25 Jun 2024
